The Goldman Sachs Group, Inc. GS
NYSE
$947.83
-11.56 (-1.20%)
A quick, factual read on the price trend and the underlying business, not a recommendation, and not a substitute for reading the numbers below yourself.
At a glance
45
Technical strength
Trend, momentum, position vs averages
- • Price is 1.1% below its 200-day moving average.
- • 14-day RSI is 37.
- • Sits at 50% of its 52-week range (0% = low, 100% = high).
41
Fundamental quality
Margins, returns, leverage, growth
- • Net margin is 18.4%.
- • Return on equity is 7.3%.
- • Revenue grew -2.3% year over year.
$967.15
Open
$959.39
Previous close
$1k
52-week high
$740.01
52-week low
42,280
Volume
2,200,168
Avg. volume
$1k
50-day avg.
+32%
Volatility (ann.)
Context
- Trading 17.9% below its 52-week high, and closer to the top of its 52-week range.
- Trading 8.2% below its 50-day average price, consistent with recent downward momentum.
- Annualized price volatility over this period is about 32%, which is moderately volatile next to a typical broad-market stock (commonly ~15-25%).
Fundamentals & valuation (FY2025, from SEC filings)
Core financials
$46.3bn
Revenue (latest FY)
Net revenues (incl. interest, net of interest expense): how banks report their top line
-2.35%
Revenue growth (YoY)
$8.5bn
Net income (latest FY)
$22.87
EPS (diluted)
$303.5bn
Total debt
$182.1bn
Cash & equivalents
+18.41%
Net margin
-23.92%
EPS growth (YoY)
$121.4bn
Net debt
$116.9bn
Shareholders' equity
-$12.6bn
Operating cash flow
$2.3bn
Capital expenditure
-$14.9bn
Free cash flow
340,800,000
Shares outstanding (basic, wtd. avg.)
345,800,000
Shares outstanding (diluted, wtd. avg.)
Valuation multiples
$947.83
Price
$294.4bn
Market cap
$415.9bn
Enterprise value
41.4x
P/E ratio
9.0x
EV / Sales
2.5x
Price / Book
-5.06%
FCF yield
+1.42%
Dividend yield
Growth & returns
-2.35%
Revenue growth (YoY)
-23.92%
EPS growth (YoY)
+7.28%
ROE
+0.51%
ROA
Credit metrics & WACC inputs
1.58
Beta (vs. S&P 500)
$303.5bn
Total debt
$182.1bn
Cash & equivalents
$121.4bn
Net debt
In the news
- Goldman Sachs | History, Growth, Controversies, & Notable Alumni
Britannica · 2026-09-19
- Goldman Sachs (GS) Rises Higher Than Market: Key Facts
Yahoo Finance · 2026-09-21
- Goldman Sachs Group Invests $400 Million in Cyera
marketscreener.com · 2026-09-22
- Goldman Sachs sees slightly softer fixed income, currencies, commodities business, higher costs
Reuters · 2026-09-16
- Goldman Sachs invests $400 million in Cyera as AI programs act on sensitive data
Stock Titan · 2026-09-22
- REG - Oxford Biomedica PLC Goldman Sachs Group. - Holding(s) in Company
tradingview.com · 2026-09-22
Want to go further?
Build your own investment report from this data. Pick a report type, add your thesis, and export a PDF.